Civilization Ventures
San Francisco, California, United StatesFounded 2017
Civilization Ventures is a San Francisco-based venture capital firm founded in 2017 that invests in scientific founders focused on cutting-edge innovations in health tech, biology, and AI. The firm manages over $200M in capital and has partnered with 70+ companies across genomics, gene editing, diagnostics, and value-based care.
55% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (2 deals in the last 12 months vs 6 prior). Average disclosed round size is $35.4M (across 40 rounds with reported amounts).
Portfolio
34
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
SL
Sarah Loveland, PhD
Senior Associate
CK
Carli Kaleta, PhD Candidate
Associate Intern
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
44 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Syntax | Series A | $14.4M | Jun 2026 |
 10X | Seed | $4.8M | Apr 2026 |
 Tacit Therapeutics | Series A | $19M | Jan 2026 |
| IIantrek | Series C | $42M | Aug 2025 |
 Tahoe Therapeutics | Series A | $30M | Aug 2025 |
 Antheia | Series C | $56M | Jun 2025 |
 Nanite | Unknown | — | Feb 2025 |
| OOxford Cancer Analytics (OXcan) | Series A | $11M | Jan 2025 |
| IIantrek | Series C | — | Jan 2025 |
| Tahoe Therapeutics | Unknown | $30M | Jan 2025 |
| OOXcan | Series A | $11M | Jan 2025 |
 Integrated Biosciences | Seed | — | Oct 2024 |
 Outpace | Series B | $144M | Aug 2024 |
 BillionToOne | Series D | $130M | Jun 2024 |
| OOutpace Bio | Series B | $144M | Jan 2024 |
 Aperiam Bio | Seed | $9M | Nov 2023 |
 Foresight Diagnostics | Series B | $58.8M | Apr 2023 |
 Wyndly | Seed | $2M | Feb 2023 |
 Evonetix | Series B | $30M | Feb 2023 |
 Kernal Biologics | Series A | $25M | Jul 2022 |
| BillionToOne | Series C | $125M | Mar 2022 |
 Omada | Series E | $192M | Feb 2022 |
| RRewrite Therapeutics | Series A | $2M | Jan 2022 |
 Glyphic Biotechnologies | Seed | $6.0M | Jul 2021 |
| Foresight Diagnostics | Series A | $12.5M | Jun 2021 |
Page 1 of 2
Top Co-Investors
Y Combinator10 shared
Hummingbird Ventures6 shared
Libertus Capital5 shared
Pear VC5 shared
Neotribe Ventures4 shared
Pacific 8 Ventures4 shared
Playground Global4 shared
Mubadala Ventures4 shared
Illumina Ventures4 shared
Wing Venture Capital4 shared
U.S. Venture Partners3 shared
Fifty Years3 shared
Alexandria Venture Investments3 shared
RA Capital Management3 shared
aMoon3 shared
HOF Capital3 shared
Initialized Capital3 shared
General Catalyst3 shared
Amplify Partners3 shared
Databricks Ventures3 shared
Last updated: 7 October 2026